Extended Data Table 1|.
Participant demographics
| Variable | Total N=41 N (%) |
Lymph node N=14 N (%) |
|---|---|---|
| Age (median [range]) | 37 (28-73) | 37 (28-52) |
| Sex | ||
| Female | 18 (43.9) | 8 (57.1) |
| Male | 23 (56.1) | 6 (42.9) |
| Race | ||
| White | 30 (73.2) | 11 (78.6) |
| Asian | 9 (22) | 2 (14.3) |
| Black | 1 (2.4) | 1 (7.1) |
| Other | 1 (2.4) | 0 (0) |
| Ethnicity | ||
| Not of Hispanic, Latinx, or Spanish origin | 39 (95.1) | 13 (92.9) |
| Hispanic, Latinx, Spanish origin | 2 (4.9) | 1 (7.1) |
| BMI (median [range]) | 25.4 (21.4-40) | 23.9 (21.4-40) |
| Comorbidities | ||
| Lung disease | 2 (4.9) | 1 (7.1) |
| Diabetes mellitus | 0 (0) | 0 (0) |
| Hypertension | 7 (17.1) | 2 (14.3) |
| Cardiovascular | 0 (0) | 0 (0) |
| Liver disease | 0 (0) | 0 (0) |
| Chronic kidney disease | 0 (0) | 0 (0) |
| Cancer on chemotherapy | 0 (0) | 0 (0) |
| Hematological malignancy | 0 (0) | 0 (0) |
| Pregnancy | 0 (0) | 0 (0) |
| Neurological | 0 (0) | 0 (0) |
| HIV | 0 (0) | 0 (0) |
| Solid organ transplant recipient | 0 (0) | 0 (0) |
| Bone marrow transplant recipient | 0 (0) | 0 (0) |
| Hyperlipidemia | 1 (2.4) | 0 (0) |
| Confirmed SARS-CoV-2 infection | 8 (19.5) | 0 (0) |
| Time from SARS-CoV-2 infection to baseline visit in days (median [range]) | 122 (50-307) | -- |